Toggle navigation
Home
Search
Services
Blog
Contact
About
(Z)-Diene Diels/Alder Routes to Cochleamycins
Gleason, Mark M.
University of Michigan Ann Arbor, Ann Arbor, MI, United States
Search 3 grants from Mark Gleason
Search grants from University of Michigan Ann Arbor
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
University of Medicine & Dentistry of NJ
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Multiplexed point-of-care molecular detection for multiple infections in co-endemic settings
Next Generation ABO Genetics and Genomics
Biological Significance of Uromodulin
Functional Status in Chronic Facial Pain
Characterization of Protective Immune Responses to Respiratory Syncytial Virus
Recently added grants:
Synaptic Processing in the Vestibular System
MyD88-dependent B cell dysfunction and autoimmunity during chronic liver disease
Epigenetic Mechanisms in Type 1 Diabetes
Dynamics and Health Consequences of Obesity between Infancy and Young Adulthood in the United States
Vascular ion channels and microcirculation in neonatal urinary tract obstruction
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32CA076216-01
Application #
2449454
Study Section
Special Emphasis Panel (ZRG3-MCHA (01))
Project Start
1998-07-01
Project End
Budget Start
1997-08-01
Budget End
1998-07-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
University of Michigan Ann Arbor
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Related projects
NIH 1998
F32 CA
(Z)-Diene Diels/Alder Routes to Cochleamycins
Gleason, Mark M. / University of Michigan Ann Arbor
NIH 1997
F32 CA
(Z)-Diene Diels/Alder Routes to Cochleamycins
Gleason, Mark M. / University of Michigan Ann Arbor
Comments
Be the first to comment on Mark Gleason's grant